A Phase II Trial of Geriatric Assessment‐Guided Selection of Treatment Intensity in Older Adults With AML is a research paper published in American Journal of Hematology (2025). On theSindex it has a DataRank of 0.411. It has been cited 8 times, with 6 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0.0816
From 3 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 6 citers.
Division of Cancer Prevention, National Cancer Institute
Grant: R37 CA276928
National Cancer Institute
Grant: P30 CA036727
National Institute of General Medical Sciences
Grant: U54 GM115458
FWCI
7.86
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals